> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bill to Stockpile Pediatric Cancer Drugs
- URL: https://www.fdaweb.com/bill-to-stockpile-pediatric-cancer-drugs/
- Published: 2024-01-12T12:00:00.000Z
- Updated: 2026-09-14T14:20:19.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156130

U.S. Reps. **Anna G. Eshoo** (D-CA), **Diana DeGette** (D-CO) and **Kim Schrier** (D-WA) have introduced the Pediatric Cancer Drug Supply Act of 2024, legislation that is intended to ensure there is a stable supply of essential pediatric cancer drugs in the U.S.

The bill would direct HHS to establish a program to create a reserve supply of essential pediatric cancer drugs by contracting with eligible drug manufacturers to stockpile the medicines. “As part of the contract, drug manufacturers would receive payments from HHS based on the quantity and cost of pediatric cancer drugs held in reserve,” the lawmakers say. “HHS would have authority to order manufacturers to distribute drugs from the buffer stocks into the commercial market to alleviate or prevent drug shortages.”

The bill text is available [here](https://eshoo.house.gov/sites/evo-subsites/eshoo.house.gov/files/evo-media-document/eshoo%5F046%5Fxml.pdf?ref=fdaweb.com).